萨瑞普塔治疗 SRPT
$17.82 +$0.25 (+1.42%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $17.82 0.00%
开盘$18.77
昨收$17.57
当日区间$17.52 – $18.77
成交量2.60M
市值$1.91B
市盈率（TTM）–
股息率–
SRPT 相关新闻
匹配 Sarepta Therapeutics 或代码 SRPT 的头条新闻，按最新排序。
- J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Announces Target Price $20
- William Blair Initiates Sarepta Therapeutics(SRPT.US) With Hold Rating
- Citi Maintains Sarepta Therapeutics(SRPT.US) With Sell Rating, Maintains Target Price $13
- Needham Maintains Sarepta Therapeutics(SRPT.US) With Sell Rating
- J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Raises Target Price to $23 正面
- J.P. Morgan Remains a Hold on Sarepta Therapeutics (SRPT)
- J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating
- Barclays Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $20
- A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $5 to $38
- Evercore Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $19
- Wolfe Research Upgrades Sarepta Therapeutics(SRPT.US) to Buy Rating, Announces Target Price $27 正面
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)
- Morgan Stanley Maintains Sarepta Therapeutics(SRPT.US) With Hold Rating, Maintains Target Price $25
- Mizuho Securities Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Maintains Target Price $31
- Tradr 2X Long SRPT Daily ETF: Tradr 2X Long SRPT Daily ETF - Anticipated Liquidation/Anticipated Cash Settlement Option Symbol: SRPU
暂无评论——快来第一个聊聊 SRPT。
登录后参与讨论。